Merit Medical Systems, Inc. (NASDAQ:MMSI) Q3 2022 Earnings Conference Call October 26, 2022 5:00 PM ET
Company Participants
Fred Lampropoulos - President & CEO
Brian Lloyd - Chief Legal Officer & Corporate Secretary
Raul Parra - CFO
Conference Call Participants
Jayson Bedford - Raymond James
Larry Biegelsen - Wells Fargo
Mike Matson - Needham & Company
William Plovanic - Canaccord Genuity
Jason Bednar - Piper Sandler
Jim Sidoti - Sidoti & Company
Michael Petuski - Barrington Research
Operator
Good day and thank you for standing by. Welcome to the Merit Medical Systems Third Quarter 2022 Earnings Conference Call. [Operator Instructions] Please be aware that today’s conference is being recorded.
I would now like to hand the conference over to your speaker today Fred Lampropoulos. Please go ahead.
Fred Lampropoulos
Thank you and welcome, everyone, to Merit Medical System’s third quarter of fiscal year 2022 earnings conference call. I’m joined on the call today by Raul Parra, our Chief Financial Officer and Treasurer; and Brian Lloyd, our Chief Legal Officer and Corporate Secretary. Brian, would you mind taking us through the Safe Harbor provisions, please?
Brian Lloyd
Thank you, Fred. I would like to remind everyone that this presentation contains forward-looking statements that receive Safe Harbor protection under federal securities laws. Although we believe these forward-looking statements are based upon reasonable assumptions, they are subject to unknown risks and uncertainties. The realization of any of these risks or uncertainties, as well as extraordinary events or transactions impacting our company, could cause actual results to differ materially from those currently anticipated. In addition, any forward-looking statements represent our views only as of today, October 26, 2022 and should not be relied upon as representing our views as of any other date. We specifically disclaim any obligation to update such statements, except as required by applicable law. Please refer to the section entitled Cautionary Statement Regarding Forward-Looking Statements in today’s presentation for important information regarding such statements. Please also refer to our most recent filings with the SEC for a discussion of factors that could cause actual results to differ from these forward-looking statements.
Our financial statements are prepared in accordance with accounting principles which are generally accepted in the United States. However, we believe certain non-GAAP financial measures provide investors with useful information regarding the underlying business trends and performance of our ongoing operations and can be useful for period-over-period comparisons of such operations. This presentation also contains certain non-GAAP financial measures. A reconciliation of non-GAAP financial measures to the most directly comparable U.S. GAAP measures is included in today’s press release and presentation furnished to the SEC under Form 8-K. Please refer to the section of our presentation entitled Non-GAAP Financial Measures for important information regarding non-GAAP financial measures discussed on this call.